Company Analysis
Sign in

Protara Therapeutics, Inc. (TARA)

Nasdaq: TARA · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2006
Full chart Alerts Compare
Grade5.0
◀ Past 4.0● Present 5.9▶ Future 4.9
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

16 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Protara Therapeutics, Inc.’s names, not what it holds today.

Patents granted
16
16 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and none in 2023
Applications published
15
since 2001, to Dec 31, 2025
Names they are printed under
3
a former name, its own name
By yearGrantedApplications published
'08'09'10'11'12'13'14'15'16'18'19'20'22'23'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
PROTEON THERAPEUTICS, INC. a former name
US, as the owner printed on each patent
14 granted
14 published
PROTARA THERAPEUTICS, INC. its own name
US, as the owner printed on each patent
2 granted
0 published
Protara Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 10, 202412,083,081Sterile aqueous choline salt compositionsPharmaceuticalsPROTARA THERAPEUTICS, INC.
Apr 26, 202211,311,503Sterile aqueous choline salt compositionsPharmaceuticalsPROTARA THERAPEUTICS, INC.
Jun 4, 201910,308,924Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteinsBiotechnologyPROTEON THERAPEUTICS, INC.
May 28, 201910,301,612Recombinant elastase proteins and methods of manufacturing and use thereofBiotechnologyPROTEON THERAPEUTICS, INC.
Jan 15, 201910,179,163Methods of treatment with elastasePharmaceuticalsPROTEON THERAPEUTICS, INC.
Jun 16, 20159,057,060Recombinant elastase proteins and methods of manufacturing and use thereofBiotechnologyPROTEON THERAPEUTICS, INC.
Oct 29, 20138,568,716Kit comprising elastasePharmaceuticalsPROTEON THERAPEUTICS, INC.
Oct 22, 20138,562,983System comprising elastasePharmaceuticalsPROTEON THERAPEUTICS, INC.
Sep 3, 20138,524,226Methods of prolonging patency of hemodialysis accessPharmaceuticalsPROTEON THERAPEUTICS, INC.
Aug 6, 20138,501,449Recombinant elastase proteins and methods of manufacturing and use thereofBiotechnologyPROTEON THERAPEUTICS, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jan 26, 20232023/0024844STERILE AQUEOUS CHOLINE SALT COMPOSITIONSPharmaceuticalsProtara Therapeutics, Inc. · patent 12,083,081 granted from it
Jul 2, 20202020/0208132RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFBiotechnologyPROTEON THERAPEUTICS, INC.
Feb 28, 20192019/0062718RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFBiotechnologyPROTEON THERAPEUTICS, INC.
Jan 10, 20192019/0010476Recombinant Elastase Proteins and Methods of Manufacturing and Use ThereofBiotechnologyPROTEON THERAPEUTICS, INC.
Sep 27, 20182018/0273928RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFBiotechnologyPROTEON THERAPEUTICS, INC.
Jul 26, 20182018/0208918NUCLEIC ACID MOLECULES ENCODING AUTOACTIVATING TYPE I PANCREATIC PROELASTASE PROTEINSBiotechnologyPROTEON THERAPEUTICS, INC. · patent 10,308,924 granted from it
Jun 7, 20182018/0155703RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFBiotechnologyPROTEON THERAPEUTICS, INC. · patent 10,301,612 granted from it
Nov 3, 20162016/0319267RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFBiotechnologyPROTEON THERAPEUTICS, INC.
Aug 25, 20162016/0243205RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFBiotechnologyPROTEON THERAPEUTICS, INC.
Nov 19, 20152015/0329846Recombinant Elastase Proteins and Methods of Manufacturing and Use ThereofBiotechnologyPROTEON THERAPEUTICS, INC.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton TARA · research, not advice